Dana-Farber Cancer Institute
The Visiting Scientist at Dana-Farber Cancer Institute will investigate new therapeutics using in vivo mouse models, specifically studying idarucibin treatment in colorectal cancer models and DDR pathway inhibitors in gastric cancer models. This role contributes to the institute's mission of advancing cancer research and patient care through groundbreaking scientific inquiry.
Headquarters
Boston, Massachusetts, United States
Company Size
1001-5000 employees
Founded
1947
Dana‑Farber Cancer Institute, based in Boston, MA, is a world‑leading cancer center specializing in adult and pediatric cancer treatment and research. Its physician‑scientists deliver multidisciplinary patient care and develop many of the most advanced therapies, including targeted treatments and clinical trials. Dana‑Farber combines cutting‑edge laboratory research with translational programs, prevention and survivorship services, and education to improve outcomes. Patients and clinicians turn to Dana‑Farber for its expertise, comprehensive care teams, and strong research pipeline.
Headquarters
San Francisco, CA
Company Size
201-500 employees
Founded
2018
Industry
Technology
Glassdoor Rating
4.2 / 5
Sarah Johnson
Chief Executive Officer
Michael Chen
Chief Technology Officer
Emily Williams
VP of Engineering
David Rodriguez
VP of Product
Jessica Thompson
Chief Financial Officer
Andrew Park
VP of Sales
View leadership team, funding history,
and employee contacts for Dana-Farber Cancer Institute.
35% below the average for this role
DNA company aids Horry Co. in solving cold cases
Nov 26, 2025
Senior Scientist, In Vivo Pharmacology
AstraZeneca
Scientist I, In Vivo Pharmacology
AbbVie
Postdoctoral Fellow – In Vivo Pharmacology and Translational Oncology
Cursor
Visiting Scientist
The Wistar Institute
Biology Scientists (In Vivo)
Makro Scientific
Research Technician, University of Arizona Cancer Center (Full-Time)
Arizona State Jobs